cp094 has been researched along with 3,4-dihydroxypyridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
el-Jammal, A; Howell, PL; Li, N; Templeton, DM; Turner, MA | 1 |
Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G | 1 |
Dobbin, P; Hershko, C; Hider, RC; Link, G; Peter, HH; Pinson, A | 1 |
3 other study(ies) available for cp094 and 3,4-dihydroxypyridine
Article | Year |
---|---|
Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
Topics: Antithyroid Agents; Copper; Deferiprone; Iron Chelating Agents; Ligands; Potentiometry; Pyridones; Spectrophotometry | 1994 |
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship | 1993 |
Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
Topics: Animals; Cell Membrane; Cells, Cultured; Deferoxamine; Iron; Iron Chelating Agents; Kinetics; Lipid Peroxidation; Malondialdehyde; Myocardium; Pyridones; Rats | 1991 |